Trials / Recruiting
RecruitingNCT07169799
Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
Evaluating the Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | trūFreeze® Spray Cryotherapy System (STERIS Endoscopy) | This treatment consists of performing a diagnostic EGD to identify GAVE lesions. A catheter advances through the therapeutic channel to treat target areas with cryotherapy. |
Timeline
- Start date
- 2026-12-22
- Primary completion
- 2028-09-30
- Completion
- 2028-12-31
- First posted
- 2025-09-12
- Last updated
- 2026-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07169799. Inclusion in this directory is not an endorsement.